Your browser doesn't support javascript.
loading
Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial.
Galactionova, Katya; Loibl, Sibylle; Salari, Paola; Marmé, Frederik; Martin, Miguel; Untch, Michael; Bonnefoi, Hervé R; Kim, Sung-Bae; Bear, Harry D; McCarthy, Nicole; Gelmon, Karen A; García-Sáenz, José A; Kelly, Catherine M; Reimer, Toralf; Toi, Masakazu; Rugo, Hope S; Gnant, Michael; Makris, Andreas; Burchardi, Nicole; Schwenkglenks, Matthias.
Afiliação
  • Galactionova K; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland.
  • Loibl S; German Breast Group, Neu-Isenburg, Germany.
  • Salari P; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland.
  • Marmé F; Medical Faculty Mannheim, Heidelberg University, University Hospital Mannheim, Mannheim, Germany.
  • Martin M; Instituto de Investigacion Sanitaria Gregorio Marañon, Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Universidad Complutense, Madrid, Spain.
  • Untch M; Spanish Breast Cancer Group, Grupo Español de Investigación en Cáncer de Mama (GEICAM), Madrid, Spain.
  • Bonnefoi HR; Department of Obstetrics and Gynaecology, Helios Kliniken Berlin-Buch, Berlin, Germany.
  • Kim SB; Department of Medical Oncology, Institut Bergonié and Université de Bordeaux Institut National de la Santé et de la Recherche Médicale (INSERM) U916, Bordeaux, France.
  • Bear HD; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • McCarthy N; Division of Surgical Oncology, Massey Cancer Center, Virginia Commonwealth University, Virginia Commonwealth University (VCU) Health, Richmond, VA, United States.
  • Gelmon KA; Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia.
  • García-Sáenz JA; Department of Medical Oncology, University of Queensland, Brisbane, QLD, Australia.
  • Kelly CM; BC Cancer, Vancouver, BC, Canada.
  • Reimer T; Instituto de Investigación Sanitaria del Hospital Clinico San Carlos (IdISSC), Madrid, Spain.
  • Toi M; Grupo Español de Investigación en Cáncer de Mama (GEICAM), Madrid, Spain.
  • Rugo HS; Mater Private Hospital, Cancer Trials Ireland, Dublin, Ireland.
  • Gnant M; Department of Obstetrics and Gynecology, University of Rostock, Rostock, Germany.
  • Makris A; Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Burchardi N; University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, United States.
  • Schwenkglenks M; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Front Oncol ; 12: 886831, 2022.
Article em En | MEDLINE | ID: mdl-36132153
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article